FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a bioactive coating for bone tissue repair. Bioactive coating for bone tissue recovery containing hydroxyapatite or fluorapatite with particle size of not more than 10 mcm and 5–10 wt% gelatin aqueous solution, taken in certain proportions.
EFFECT: above described coating of maximally close composition to bone tissue has high adhesion strength (tensile strength), low porosity, providing high microhardness on the surface of the implant or damaged tissue, with high biodegradation.
1 cl, 3 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
HYDROXYAPATITE-BASED COMPOSITE MATERIAL FOR BONE IMPLANTS AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2771382C1 |
BIOACTIVE COMPOSING MATERIAL FOR REPLACEMENT OF BONE DEFECTS AND METHOD FOR PRODUCING THEREOF | 2018 |
|
RU2683255C1 |
BIOMEDICAL MATERIAL BASED ON HYDROXYAPATITE AND METHOD FOR ITS PRODUCTION | 2022 |
|
RU2782925C1 |
BIORESORBABLE MATERIAL AND METHOD FOR PRODUCING THEREOF | 2017 |
|
RU2652429C1 |
BIOMATERIAL BASED ON HYDROXYAPATITE | 2020 |
|
RU2735032C1 |
METHOD FOR MANUFACTURING GRANULES FROM BIOACTIVE MATERIAL BASED ON HYDROXYAPATITE OR FLUORAPATITE | 2021 |
|
RU2753529C1 |
DRY MIXTURE BASED ON HYDROXYAPATITE FOR AQUEOUS SUSPENSIONS FOR COATING ON BONE IMPLANTS AND AQUEOUS SUSPENSION BASED ON IT | 2022 |
|
RU2797279C1 |
COMPOSITE BIOMATERIAL BASED ON HYDROXYAPATITE AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2816008C1 |
BIOMATERIAL BASED ON HYDROXYAPATITE | 2020 |
|
RU2741208C1 |
BIOACTIVE COMPOSITE MATERIAL | 2020 |
|
RU2724611C1 |
Authors
Dates
2020-03-25—Published
2019-08-19—Filed